Effects of metronidazole and tinidazole on NTPDase1 and ecto-5′-nucleotidase from intact cells of Trichomonas vaginalis

FEMS Microbiology Letters

Volumn 226, Issue 2, 2003, Pages 379-384

  Tasca, Tiana ^a,b   Borges, Fernanda Pires ^b   Bonan, Carla Denise ^b   De Carli, Geraldo Attilio ^b   Battastini, Ana Maria Oliveira ^a   Sarkis, João José Freitas ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Ecto 5 nucleotidase; Metronidazole; NTPDase1; Tinidazole; Trichomonas vaginalis

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; APYRASE; ECTO 5' NUCLEOTIDASE; METRONIDAZOLE; TINIDAZOLE; 5' NUCLEOTIDASE; ADENOSINE PHOSPHATE; ANTITRICHOMONAL AGENT;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; ENZYME ACTIVITY; HYDROLYSIS KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; TRICHOMONAS VAGINALIS; ANIMAL; ENZYMOLOGY; METABOLISM;

TRICHOMONAS VAGINALIS;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTITRICHOMONAL AGENTS; APYRASE; METRONIDAZOLE; TINIDAZOLE; TRICHOMONAS VAGINALIS;

EID: 0642377482     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(03)00637-2     Document Type: Article

References (38)

1. Lehker M.W., Alderete J.F. Biology of trichomonosis. Curr. Opin. Infect. Dis. 13:2000;37-45.
2. Gerbase A.C., Rowley J.T., Heyman D.H.L., Berkley S.F.B., Piot P. Global prevalence and incidence estimates of selected curable STDs. Sex. Transm. Inf. 74:1998;S12-S16.
3. Sorvillo F., Kerndt P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet. 351:1998;213-214.
4. Fleming D.T., Wasserheit J.N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Inf. 75:1999;3-17.
5. Cotch M.F., Pastorek J.G., Nugent R.P., Hillier S.L., Gibbs R.S., Martin D.H., Eschenbach D.A., Edelman R., Carey J.C., Regan J.A., Krohn M., Klebanoff M.A., Rao A.V., Rhoads G.G. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex. Transm. Inf. 24:1997;353-360.
6. Heine P., McGregor J.A. Trichomonas vaginalis: a reemerging pathogen. Clin. Obstet. Gynecol. 36:1993;137-144.
7. Gram I.T., Macaluso M., Churchill J., Stalsberg H. Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control. 3:1992;231-236.
8. Kharsany A.B., Hoosen A.A., Moodley J., Bagaratee J., Gouws E. The association between sexually transmitted pathogens and cervical intra-epithelial neoplasia in a developing community. Genitourin. Med. 69:1993;357-360.
9. Zhang Z.F., Begg C.B. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int. J. Epidemiol. 23:1994;682-690.
10. Grodstein F., Goldman M.B., Cramer D.W. Relation of tubal infertility to history of sexually transmitted diseases. Am. J. Epidemiol. 137:1993;577-584.
11. Alderete J.F., Benchimol M., Lehker M.W., Crouch M.L. The complex fibronectin-Trichomonas vaginalis interactions and Trichomonosis. Parasitol. Int. 51:2002;285-292.
12. Filippini A., Taffs R.E., Agui T., Sitkovsky M.V. Ecto-ATPase activity in cytolytic T-lymphocytes. Protection from the cytolytic effects of extracellular ATP. J. Biol. Chem. 265:1990;334-340.
13. Steinberg T.H., Di Virgilio F. Cell-mediated cytotoxicity: ATP as an effector and the role of target cells. Curr. Opin. Immunol. 3:1991;71-75.
14. Matos J.A.A., Borges F.P., Tasca T., Bogo M.R., De Carli G.A., Fauth M.G., Dias R.D., Bonan C.D. Characterisation of an ATP diphosphohydrolase (Apyrase, EC 3.6.1.5) activity in Trichomonas vaginalis. Int. J. Parasitol. 31:2001;770-775.
15. Sarkis J.J.F., Battastini A.M.O., Oliveira E.M., Frassetto S.S., Dias R.D. ATP diphosphohydrolases: An overview. J. Braz. Assoc. Adv. Sci. 47:1995;131-136.
16. Zimmermann H. Extracellular purine metabolism. Drug Develop. Res. 39:1996;337-352.
17. Heyworth P.G., Gutteridge W.E., Ginger C.D. Purine metabolism in Trichomonas vaginalis. FEBS Lett. 141:1982;106-110.
18. Heyworth P.G., Gutteridge W.E., Ginger C.D. Pyrimidine metabolism in Trichomonas vaginalis. FEBS Lett. 176:1984;55-60.
19. Edwards D.I. Nitroimidazole drugs - action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 31:1993;9-20.
20. Petrin D., Delgaty K., Bhatt R., Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin. Microbiol. Rev. 11:1998;300-317.
21. Mendz G.L., Mégraud F. Is the molecular basis of metronidazole resistance in microaerophilic organisms understood? Trends Microbiol. 10:2002;370-375.
22. Kulda J. Trichomonads, hydrogenosomes and drug resistance. Int. J. Parasitol. 29:1999;199-212.
23. Diamond L.S. The establishment of various trichomonads of animals and man in axenic cultures. J. Parasitol. 43:1957;488-490.
24. Shaio M.F., Chen J.G., Chang F.Y. A comparison of various methods for the determination of viability of parasitic flagellates. Southeast Asian J. Trop. Med. Publ. Health. 18:1987;539-546.
25. Tai K.K., Truong D.D. Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: Therapeutic implications for Parkinson's disease. J. Neurosci. Res. 69:2002;559-566.
26. Tachezy J., Kulda J., Tomková E. Aerobic resistance of Trichomonas vaginalis to metronidazole induced in vitro. Parasitology. 106:1993;31-37.
27. 2+-ATPase activity. Anal. Biochem. 157:1986;375-380.
28. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;218-254.
29. Kegel B., Braun N., Heine P., Maliszewski C.R., Zimmermann H. An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacology. 36:1997;1189-1200.
30. Drmota T., Proost P., Van Ranst M., Weyda F., Kulda J., Tachezy J. Iron-ascorbate cleavable malic enzyme from hydrogenosomes of Trichomonas vaginalis: purification and characterization. Mol. Biochem. Parasitol. 83:1996;221-234.
31. Steinbuchel A., Muller M. Anaerobic pyruvate metabolism of Tritrichomonas foetus and Trichomonas vaginalis hydrogenosomes. Mol. Biochem. Parasitol. 20:1989;57-65.
32. Cerkasovova A., Novak J., Cerkasov J., Kulda J., Tachezy J. Metabolic properties of Trichomonas vaginalis resistant to metronidazole under anaerobic conditions. Acta Univ. Carolinae Biol. 30:1988;505-512.
33. Mertens E., Van Schaftingen E., Muller M. Pyruvate kinase from Trichomonas vaginalis an allosteric enzyme stimulated by ribose 5-phosphate and glycerate-3-phosphate. Mol. Biochem. Parasitol. 54:1992;13-20.
34. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:1998;413-492.
35. Sitkovsky M.V. Extracellular purines and their receptors in immunoregulation. Review of recent advances. Nippon Ika Daigaku Zasshi. 65:1998;351-357.
36. Sneddon P., Westfall T.D., Todorov L.D., Mihaylova-Todorova S., Westfall D.P., Kennedy C. Modulation of purinergic neurotransmission. Prog. Brain Res. 120:1999;11-20.
37. Ding Y., Cesare P., Drew L., Nikitaki D., Wood J.N. ATP, P2X receptors and pain pathways. J. Auton. Nerv. Syst. 81:2000;289-294.
38. Zimmermann H. 5′-Nucleotidase: molecular structure and functional aspects. Biochem. J. 285:1992;345-365.